GMP Certified mRNA Manufacturing Site, BioNTech, Marburg, Germany
Next-gen immunotherapy company BioNTech announced this month the completion of a share purchase agreement with Swiss pharma giant Novartis AG,
Read moreNext-gen immunotherapy company BioNTech announced this month the completion of a share purchase agreement with Swiss pharma giant Novartis AG,
Read moreModerna’s COVID-19 vaccine candidate generated antibodies in all 45 patients studied in its early stage human trial, the U.S biotech
Read moreTesla Inc is engineering mobile molecule printers to help produce the future COVID-19 vaccine developed by CureVac in Germany, the
Read moreModerna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced on May 12, that
Read moreModerna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read moreThe first intermediate analysis of the Phase I Zika vaccine candidate sample (mRNA-1893) reveals that the dosage levels of 10
Read moreModerna’s mRNA Vaccines have shown promise against all 8 viruses studied in clinical trials. Clinical stage biotech company Moderna, Inc.
Read moreModerna’s first Phase 1 new coronavirus (COVID-19) vaccine trial participant has been administered the initial dose of the RNA vaccine
Read moreGrange Castle Biotechnology Plant is one of the biggest integrated biotechnology plants in the world. Owned by the world-leading biotech
Read more